Different clinical characteristics between polymicrobial and monomicrobial aeromonas bacteremia-A study of 216 cases

Internal Medicine

Volumn 49, Issue 22, 2010, Pages 2415-2421

  Lay, Chorng Jang ^a   Zhuang, Han Juan ^b   Ho, Yu Huai ^a   Tsai, Yeong Shu ^a   Wang, Lih Shinn ^a,c   Tsai, Chen Chi ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Aeromonas; Bacteremia; Monomicrobial; Polymicrobial

Indexed keywords

ANTACID AGENT;

ABDOMINAL PAIN; ABDOMINAL SURGERY; ACINETOBACTER; ADULT; AEROMONAS; AEROMONAS HYDROPHILA; AEROMONAS PUNCTATA; AEROMONAS VERONII; APACHE; ARTICLE; BACTEROIDES; BILE DUCT ADENOCARCINOMA; BILE DUCT CARCINOMA; BREAST CANCER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DRUG USE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FEVER; GASTROINTESTINAL CARCINOMA; GENDER; GRAM NEGATIVE SEPSIS; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; KLEBSIELLA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOMICROBIAL AEROMONAS BACTEREMIA; MORGANELLA MORGANII; MORTALITY; PANCREAS CANCER; PANTOEA AGGLOMERANS; POLYMICROBIAL AEROMONAS BACTEREMIA; PREVOTELLA; PROGNOSIS; PROTEUS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SERRATIA; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS; SURVIVAL RATE; THROMBOCYTOPENIA; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

AEROMONAS; AGED; BACTEREMIA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78549254203     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.4117     Document Type: Article

References (54)

1. Janda JM, Abbott SL, Carnahan AM. Aeromonas and Plesiomonas. In: Manual of Clinical Microbiology. 6th ed. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolkens RH, Eds. American Society for Microbiology, Washington, DC, 1995: 477-482.
2. Hazen TC, Fliermans CB, Hirsch RP, Esch GW. Prevalence and distribution of Aeromonas hydrophila in the United States. Appl Environ Microbiol 36: 731-738, 1978.
3. Janda JM, Abbott SL. Evolving concepts regarding the genus Aeromonas: an expanding Panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 27: 332-344, 1998.
4. Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteremia. J Infect 40: 267-273, 2000.
5. Llopis F, Grau I, Tubau F, Cisnal M, Pallares R. Epidemiological and clinical characteristics of bacteremia caused by Aeromonas spp. as compared with Escherichia coli and Pseudomonas aeruginosa. Scand J Infect Dis 36: 335-341, 2004.
6. Tena D, González-Praetorius A, Gimeno C, Pérez-Pomata MT, Bisquert J. Extraintestinal infection due to Aeromonas spp.: review of 38 cases. Enferm Infecc Microbiol Clin 25: 235-241, 2007 (in Spanish).
7. Martino R, Gómez L, Pericas R, et al. Bacteremia caused by nonglucose- fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 19: 320-323, 2000.
8. Ko WC, Chuang YC. Aeromonas bacteremia: Review of 59 episodes. Clin Infect Dis 20: 1298-1304, 1995.
9. LeChevallier MW, Seidler RJ, Evans TM. Enumeration and characterization of standard plate count bacteria in chlorinated and raw water supplies. Appl Environ Microbiol 40: 922-930, 1980.
10. Millership SE, Chattopadhyay B. Aeromonas hydrophila in chlorinated water supplies. J Hosp Infect 6: 75-80, 1985.
11. Lye DJ. A mouse model for characterization of gastrointestinal colonization rates among environmental Aeromonas isolates. Curr Microbiol 58: 454-458, 2009.
12. Dryden M, Munro R. Aeromonas septicemia: relationship of species and clinical features. Pathology 21: 111-114, 1989.
13. Tsai MS, Kuo CY, Wang MC, Wu HC, Chien CC, Liu JW. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. J Microbiol Immunol Infect 39: 150-154, 2006.
14. Duthie R, Ling TW, Cheng AF, French GL. Aeromonas septicaemia in Hong Kong species distribution and associated disease. J Infect 30: 241-244, 1995.
15. Pazzaglia G, Sack RB, Salazar E, et al. High frequency of coinfecting enteropathogens in Aeromonas-associated diarrhea of hospitalized Peruvian infants. J Clin Microbiol 16: 1151-1156, 1991.
16. Obi CL, Coker AO, Epoke J, Ndip RN. Enteric bacterial pathogens in stools of residents of urban and rural regions in Nigeria: a comparison of patients with and without diarrhoea and controls without diarrhoea. J Diarrhoeal Dis Res 15: 241-247, 1997.
17. Kirov SM, Castrisios M, Shaw JG. Aeromonas flagella (polar and lateral) are enterocyte adhesins that contribute to biofilm formation on surfaces. Infect Immun 72: 1939-1945, 2004.
18. Rotimi VO, Egwari L, Akande B. Acidity and intestinal bacteria: an in-vitro assessment of the bactericidal activity of hydrochloric acid on intestinal pathogens. Afr J Med Med Sci 19: 275-280, 1990.
19. Wu CJ, Wu JJ, Yan JJ, et al. Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan. J Infect 54: 151-158, 2007.
20. Durand B, Leclereq R, Pipau F, Cordonnier C. Evolution of bacterial susceptibility to antibiotics during a six year period in a hematology unit. J Hosp Inf 29: 19-33, 1995.
21. Rosenthal D. Epidemiology of microorganisms causing septicemia. Dtsch Med Wschr 118: 1270, 1993 (in German).
22. Jacobson K, Rolston K, Elting L, LeBlanc B, Whimbey E, Ho DH. Susceptibility surveillance among gram-negative bacilli at a cancer center. Chemotherapy 45: 325-334, 1999.
23. Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis 45: 228-233, 2007.
24. González-Barca E, Fernández-Sevilla A, Carratalá J, et al. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 18: 539-544, 1999.
25. Kern W, Kurrle E, Schmeiser T. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 18: 138-145, 1990.
26. Awada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 15: 33-48, 1992.
27. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4: 53-58, 1984.
28. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 8: 632-635, 1988.
29. Such J, Guarner C, Enriquez J, Rodriguez JL, Seres I, Vilardell F. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 6: 80-84, 1988.
30. Guarner C, Runyon BA. Macrophage function in cirrhosis and the risk of bacterial infection. Hepatology 22: 367-369, 1995.
31. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108: 1835-1841, 1995.
32. Quigley EM. Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited. Dig Dis Sci 41: 557-561, 1996.
33. Norman DA, Atkins JM, Seelig LL Jr, Gomez-Sanchez C, Krejs GJ. Water and electrolyte movement and mucosal morphology in the jejunum of patients with portal hypertension. Gastroenterology 79: 707-715, 1980.
34. Such J, Guardiola JV, de Juan J, et al. Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol 14: 371-376, 2002.
35. Schimpl G, Pesendorfer P, Steinwender G, Feierl G, Ratschek M, Höllwarth ME. Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats. Gut 39: 48-53, 1996.
36. Chiva M, Guarner C, Peralta C, et al. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol 15: 145-150, 2003.
37. Keefe DM. Intestinal mucositis: mechanisms and management. Curr Opin Oncol 19: 323-327, 2007.
38. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47: 632-637, 2000.
39. Niscola P, Scaramucci L, Romani C, et al. Mucositis in the treatment of haematological malignancies. Ann Oncol 19: vii141-vii 145, 2008.
40. Marriott I, Bost KL, Huet-Hudson YM. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J Reprod Immunol 71: 12-27, 2006.
41. Temple SE, Pham K, Glendenning P, Phillips M, Waterer GW. Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4. Cell Immunol 251: 69-71, 2008.
42. Razmara A, Krause DN, Duckles SP. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am J Physiol Heart Circ Physiol 289: H1843-H1850, 2005.
43. Losonczy G, Kriston T, Szabò A, et al. Male gender predisposes to development of endotoxic shock in the rat. Cardiovasc Res 47: 183-191, 2000.
44. Funada H, Matsuda T. Aeromonas bacteremia in patients with hematologic diseases. Intern Med 36: 171-174, 1997.
45. Harris RL, Fainstein V, Elting L, Hopfer RL, Bodey GP. Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis 7: 314-320, 1985.
46. Lee LN, Luh KT, Hsieh WC. Bacteremia due to Aeromonas hydrophila: a report of 40 episodes. Taiwan Yi Xue Hui Za Zhi 85: 123-132, 1986.
47. Janda JM, Guthertz LS, Kokka RP, Shimada T. Aeromonas species in septicemia: laboratory characteristics and clinical observations. Clin Infect Dis 19: 77-83, 1994.
48. Barillo DJ, McManus AT, Cioffi WG, McManus WF, Kim SH, Pruitt BA Jr. Aeromonas bacteremia in burn patients. Burns 22: 48-52, 1996.
49. Ferguson MR, Xu XJ, Houston CW, et al. Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila. Infect Immun 65: 4299-4308, 1997.
50. Chopra AK, Houston CW. Enterotoxins in Aeromonas-associated gastroenteritis. Microbes Infect 1: 1129-1137, 1999.
51. Galindo CL, Fadl AA, Sha J, et al. Aeromonas hydrophila cytotoxic enterotoxin activates mitogen-activated protein kinases and induces apoptosis in murine macrophages and human intestinal epithelial cells. J Biol Chem 279: 37597-37612, 2004.
52. Sha J, Kozlova EV, Chopra AK. Role of various enterotoxins in Aeromonas hydrophila-induced gastroenteritis: generation of enterotoxin gene-deficient mutants and evaluation of their enterotoxic activity. Infect Immun 70: 1924-1935, 2002.
53. Krzymińska S, Kaznowski A, Puk M. Interaction of Aeromonas spp. human isolates with murine macrophages. New Microbiol 31: 481-488, 2008.
54. Ko WC, Chiang SR, Yan JJ, Chuang YC. Comparative pathogenicity of bacteraemic isolates of Aeromonas hydrophila and Klebsiella pneumoniae. Clin Microbiol Infect 11: 553-558, 2005.